Latent vs Amgen
Side-by-side comparison of AI visibility scores, market position, and capabilities
Healthcare AI automating prior authorization documentation by reviewing patient records; $13.1M from General Catalyst and YC achieving $2.4M revenue competing with Cohere Health for pharmacy workflow automation.
About
Latent is a San Francisco-based healthcare AI company automating clinical operations for pharmacy and medication access workflows — using AI to review patient medical records, generate evidence-based prior authorization documentation, and streamline the clinical justification process that currently requires pharmacists and clinical staff to spend significant time on administrative documentation that delays patients' access to medications. Founded in 2022 and a Y Combinator W23 graduate, Latent raised $13.1 million from General Catalyst and Y Combinator, achieving $2.4 million in revenue in 2024.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
About
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.